|
ZNF460 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.021800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.424400E-03 |
| Normal-vs-Stage2 |
2.088200E-02 |
| Normal-vs-Stage3 |
9.716500E-02 |
| Normal-vs-Stage4 |
2.016300E-02 |
| Stage1-vs-Stage2 |
4.471400E-01 |
| Stage1-vs-Stage3 |
1.836990E-01 |
| Stage1-vs-Stage4 |
8.036000E-01 |
| Stage2-vs-Stage3 |
5.385600E-01 |
| Stage2-vs-Stage4 |
8.194800E-01 |
| Stage3-vs-Stage4 |
5.071600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.742500E-03 |
| Normal-vs-AfricanAmerican |
4.256400E-03 |
| Normal-vs-Asian |
3.783500E-04 |
| Caucasian-vs-AfricanAmerican |
7.965400E-01 |
| Caucasian-vs-Asian |
3.590100E-02 |
| AfricanAmerican-vs-Asian |
6.127800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.997140E-03 |
| Normal-vs-Female |
3.432100E-02 |
| Male-vs-Female |
2.883500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.696590E-03 |
| Normal-vs-Extreme_Weight |
1.242830E-03 |
| Normal-vs-Obese |
4.050000E-02 |
| Normal-vs-Extreme_Obese |
7.461800E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.383400E-01 |
| Normal_Weight-vs-Obese |
4.176300E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.609200E-01 |
| Extreme_Weight-vs-Obese |
2.543600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.952200E-01 |
| Obese-vs-Extreme_Obese |
3.871400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.149000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.399700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.240300E-03 |
| Normal-vs-Age(81-100Yrs) |
1.262030E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.058200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.590030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.918000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.959000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.426400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.392800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.396700E-03 |
| Normal-VS-Type2 PRCC |
2.164100E-03 |
| Normal-VS-KIRP CIMP |
6.436200E-01 |
| Normal-VS-Unclassified PRCC |
3.822300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.464400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.051190E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.446400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.014370E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.208000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.137640E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.449000E-04 |
| Normal-vs-N1 |
3.644200E-01 |
| Normal-vs-N2 |
3.917600E-01 |
| N0-vs-N1 |
4.165500E-02 |
| N0-vs-N2 |
2.321000E-01 |
| N1-vs-N2 |
6.934600E-01 |
|
|
